Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker STLN
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K/A | 8-K ↗ |
| Nov 12, 2026 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 5, 2026 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 2, 2026 | STLN Starling Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 21, 2026 | STLN Starling Oncology, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Aug 21, 2026 | STLN Starling Oncology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 6, 2026 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 3, 2026 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 3, 2026 | STLN Starling Oncology, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jul 7, 2026 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 7, 2026 | STLN Starling Oncology, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jul 7, 2026 | STLN Starling Oncology, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jul 7, 2026 | STLN Starling Oncology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 18, 2026 | STLN Starling Oncology, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 22, 2026 | STLN Starling Oncology, Inc. | 1.05 Material Cybersecurity Incidents | 8-K | 8-K ↗ |
| May 7, 2026 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 13, 2026 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 12, 2026 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 23, 2026 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 23, 2026 | STLN Starling Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jan 12, 2026 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 7, 2026 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 7, 2026 | STLN Starling Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 1, 2025 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 1, 2025 | STLN Starling Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 14, 2025 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 13, 2025 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 6, 2025 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 13, 2025 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 13, 2025 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 13, 2025 | STLN Starling Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 19, 2025 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 14, 2025 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 8, 2025 | STLN Starling Oncology, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 7, 2025 | STLN Starling Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Apr 11, 2025 | STLN Starling Oncology, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 27, 2025 | STLN Starling Oncology, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Mar 27, 2025 | STLN Starling Oncology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 25, 2025 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 25, 2025 | STLN Starling Oncology, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Mar 25, 2025 | STLN Starling Oncology, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Mar 25, 2025 | STLN Starling Oncology, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Mar 25, 2025 | STLN Starling Oncology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 24, 2025 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 24, 2025 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 26, 2025 | STLN Starling Oncology, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 26, 2025 | STLN Starling Oncology, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 19, 2024 | STLN Starling Oncology, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Nov 13, 2024 | STLN Starling Oncology, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 12, 2024 | STLN Starling Oncology, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
50 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:56 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances